The US International Trade Commission ruled that Chinese firm Innoscience infringed on a patent held by American rival EPC, affecting its IPO plans in Hong Kong. Innoscience plans to appeal the decision but assures customers of no impact on its products.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing